EBP Y1 Flashcards
(51 cards)
What are randomised control trials good for?
Answering treatment and diagnosis questions.
They are considered the most reliable evidence when investigating the effect of an intervention.
?: volunteers are recruited from a sample of population, assesed for eligability and randomly assigned to groups. Investigation attempt to completely control the exposure.
What does PICOt stand for?
P: Patient/population/problem
I: intervention
C: comparison/control
O: outcome
When are randomised control trials usually used?
commonly used to verify the efficacy of a new treatment. EG: drug trials

What are the key features of a randomised control trial?
- Randomly allocated
- Always a control group
What are the issues with randomised control trials?
- Expensive
- Appropreate: not always the right study design to answer the question
- Ethical: is it ethihcal to randomly assign treatment?
What is the major difference between controlled and uncontrolled studies?
uncontrolled: all participants given the same new treatment no directly comparable group
cannot compare effects with any other group who didn’t recieve treatment
Controlled: presence of a comparison group. Allows for potential bias due to external influences during the study
What does concealment mean?
Sequence of treatment allocation is unknown, helps reduce posibility of interence with group allocations to maintain randomisation.
What does blinding mean?
Where the actual treatment allocation is unknown. Instead of groups placebo and drug its drug A and drug B
There is single blind trial and double blind trial
What is a parallel group trial?
Comparison of two treatments, random allocation. Can be two completely separate treatments or different doeses of the same.
What is a cross over trial?
What are teh advantages and disadvantages of this?
Patients recieve a sequence of at least two treatments during different time periods. They cross over treatments to another during the trial.
More balanced, participants recive same number of treatments, each paticipant will recive all treatments.
Advantages: Each participant is thier own matched control so it requires fewer participants, reduction in variability.
Disadvantages: Potential for carryover effect, response to previous treatment effectng response for current treatment, this causes bias.
washout period is the time between treatment periods.
What can be done about non-compliance?
- per-protocol : exclude data from the individual who didn’t comply
- As-Treated: reassign the individual to the control group
- Intention-to-treat: keep to individual in thier original randomised group
What are the two conditions of intention to treat?
- all randomised participants should be included in the analysis
- All participants are retained in the group to which they were randomised.
considered misrepresentitive of the data
What are the different types of bias?
- Selection: systematic differences in the baseline characteristics between treatment groups
- Performance: differneces in care or other exposures between treatment in groups than teh intervention of interest.
- Attrition bias: difference in the withdrawals between treatment groups
- Detection or assessor bias: difference between treatment groups and how outcomes are measured/determined
- Reporting bias: difference between the reported and unreported findings.
What is the ideal study design?
- randomisation of pateints
- a concurrent control group
- double-blinding of pateints and assesors
What is the number needed to treat?
The average number of pateints who need to be treated to prevent an additional negative outcome
if NNT = 1 : everyone from intervention group has improved
NNT = 1/ absolute risk reduction
If the outcome of a trial is continuous how is the difference expressed?
Difference in means
confidence intervals
strength of evidence “p”
What is the number needed to harm?
represents the number of pateints who would need to take the intervention for one pateint to experience a harmful event of interest. This number should be as high as possible
NNH = 1/ absolute risk increase
critical appraisal
RAMMbo
what is on the xfactor of making evidence based decisions?
- epidemiological evidence
- system features: economic legal, political, public health
- patient clinical circumstances: physical health, social, psycological
- values and preferences: person, family, community, practitioner
What increases the strength of the evidence?
The more its reviewed and summarised. IE not the original studies
what are the types of questions?
Background: what is hypertension? How is blood pressure regulated?
Foreground: What happens when pateints with hypertension don’t get treatment?
What are the benefits home home monitoring blood pressure?
